In vitro activity of the new semi-synthetic polypeptide cilofungin (LY121019) against Aspergillus and Candida species
- PMID: 2226501
- DOI: 10.1007/BF01964276
In vitro activity of the new semi-synthetic polypeptide cilofungin (LY121019) against Aspergillus and Candida species
Abstract
The in vitro activity of cilofungin (LY121019), a new semi-synthetic antifungal agent was evaluated. Potent activity was seen against Candida albicans and Candida tropicalis, with almost identical MIC and MFC results, whereas no activity was seen against any isolates of Candida parapsilosis or three Aspergillus spp. However, MICs were dependent on medium and test conditions chosen. It is concluded that cilofungin has good activity against some medically important yeasts in vitro, and that its in vitro activity depends on the method used.
Similar articles
-
Cilofungin (LY121019), an antifungal agent with specific activity against Candida albicans and Candida tropicalis.Antimicrob Agents Chemother. 1988 Sep;32(9):1331-5. doi: 10.1128/AAC.32.9.1331. Antimicrob Agents Chemother. 1988. PMID: 3058017 Free PMC article.
-
Fungicidal activity of cilofungin (LY121019) alone and in combination with anticapsin or other antifungal agents.Eur J Clin Microbiol Infect Dis. 1989 Jun;8(6):564-7. doi: 10.1007/BF01967483. Eur J Clin Microbiol Infect Dis. 1989. PMID: 2504601
-
Activity of cilofungin (LY121019) against Candida species in vitro.J Antimicrob Chemother. 1988 Dec;22(6):891-7. doi: 10.1093/jac/22.6.891. J Antimicrob Chemother. 1988. PMID: 3243737
-
Candida and candidaemia. Susceptibility and epidemiology.Dan Med J. 2013 Nov;60(11):B4698. Dan Med J. 2013. PMID: 24192246 Review.
-
In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature.Rev Iberoam Micol. 2003 Dec;20(4):121-36. Rev Iberoam Micol. 2003. PMID: 15456349 Review.
Cited by
-
Aerosol and parenteral pneumocandins are effective in a rat model of pulmonary aspergillosis.Antimicrob Agents Chemother. 1995 Aug;39(8):1784-9. doi: 10.1128/AAC.39.8.1784. Antimicrob Agents Chemother. 1995. PMID: 7486919 Free PMC article.
-
In vitro evaluation of the pneumocandin antifungal agent L-733560, a new water-soluble hybrid of L-705589 and L-731373.Antimicrob Agents Chemother. 1995 May;39(5):1070-6. doi: 10.1128/AAC.39.5.1070. Antimicrob Agents Chemother. 1995. PMID: 7625791 Free PMC article.
-
In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi.Antimicrob Agents Chemother. 2000 Jan;44(1):57-62. doi: 10.1128/AAC.44.1.57-62.2000. Antimicrob Agents Chemother. 2000. PMID: 10602723 Free PMC article.
-
Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthase.Antimicrob Agents Chemother. 1994 Jul;38(7):1480-9. doi: 10.1128/AAC.38.7.1480. Antimicrob Agents Chemother. 1994. PMID: 7979276 Free PMC article.
-
Efficacy of cilofungin therapy administered by continuous intravenous infusion for experimental disseminated candidiasis in rabbits.Antimicrob Agents Chemother. 1992 Jan;36(1):56-8. doi: 10.1128/AAC.36.1.56. Antimicrob Agents Chemother. 1992. PMID: 1590700 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous